Sirius Therapeutics Raises Nearly $50M in Series B2 Funding

Here’s a summary based on the provided information about Sirius Therapeutics:
Company Overview
- Startup: Sirius Therapeutics
- Website: siriusrna.com
- Founded: 2021
- Founder: Dr. Qunsheng Ji
- Location: San Diego, CA
Fundraising Details
- Funding Round: Series B2
- Amount Raised: Nearly $50M
- Total Raised to Date: Nearly $150M
- Date of Funding: October 5, 2025
Investors
- Lead Investor: Undisclosed
- Participating Investors:
- BioTrack Capital
- OrbiMed
- Creacion Ventures
- Hankang Capital
Purpose of Funding
- To advance clinical development of siRNA therapeutics for cardiometabolic disorders.
- To grow new RNA delivery technologies.
This outlines the key details of Sirius Therapeutics’ funding and operations as of the specified date.
Source link
2025-05-10 14:30:27
Leave a Reply
You must be logged in to post a comment.